Replies to post #26587 on Marker Therapeutics Inc (MRKR)

[Inoviorulez]

Thanks for finding that out, that makes sense. Considering they were so eager to submit the PC data for ASCO I believe it should be pretty decent. The only reason it wasn't accepted was because that part of the track they signed up for didn't allow for release of data. However, it looks like they are presenting the PC data in July at AACR 2019.